Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Payables (2016 - 2025)

Bio Key International (BKYI) has disclosed Payables for 16 consecutive years, with $975481.0 as the latest value for Q3 2025.

  • Quarterly Payables fell 37.66% to $975481.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $975481.0 through Sep 2025, down 37.66% year-over-year, with the annual reading at $2.3 million for FY2024, 78.13% up from the prior year.
  • Payables hit $975481.0 in Q3 2025 for Bio Key International, up from $889026.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $4.4 million in Q2 2023 to a low of $309323.0 in Q1 2021.
  • Historically, Payables has averaged $1.7 million across 5 years, with a median of $1.3 million in 2022.
  • Biggest five-year swings in Payables: tumbled 89.4% in 2021 and later surged 765.99% in 2022.
  • Year by year, Payables stood at $427772.0 in 2021, then soared by 765.99% to $3.7 million in 2022, then crashed by 64.48% to $1.3 million in 2023, then soared by 78.13% to $2.3 million in 2024, then tumbled by 58.39% to $975481.0 in 2025.
  • Business Quant data shows Payables for BKYI at $975481.0 in Q3 2025, $889026.0 in Q2 2025, and $568836.0 in Q1 2025.